DMII

Drugs Made In America Acquisition II Corp.

$10.23

-0.00%
SectorFinancial ServicesIndustryShell CompaniesCountryUnited States

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Source: Yahoo Finance
Q-Score—/ 100
Market Cap$651.7M
P/E50.05
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta-0.01
AI summary

Price & performance

1M+0.3%
3M+1.0%
YTD+2.9%
1Y—
52-week range—
Beta-0.01
Full chart and returns against a benchmark

Q-Score

—/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk81
Performance72
Valuation42
Profitability—
Leverage—
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · Q2 2026

Revenue—
Net income$4.4M
Net margin—
Historical fundamentals

Red flags in filings

3active red flags
Going-concern doubtApr 15, 2026
Material weakness in controlsApr 15, 2026
Late filing noticeApr 1, 2026
Filings, findings and the timeline

Valuation

DMIIIndustryP/E50.0564.76P/S——EV/EBITDA——P/B——PEG——
Dividend yield0.00%
Every valuation metric